Zydus Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

10,818.70

8,731.60

7,981.90

7,790.40

6,347.40

Operating profit

4,058.70

2,454.40

1,918.10

2,319.10

1,423.10

Interest

390.70

278.20

134.90

70.90

233.90

Gross profit

4,752.80

2,724.60

1,961.90

2,327.10

2,038.60

EPS (Rs)

34.21

15.11

8.38

14.42

13.80

Other income

1,084.80

548.40

178.70

78.90

849.40

Stock adjustment

-131.70

105.10

-46.90

-148.30

15.50

Raw material

3,001.40

2,703.50

2,629.00

2,346.40

1,838.30

Power and fuel

-

-

-

-

-

Employee expenses

1,507.50

1,321.90

1,204.90

1,147.30

1,077.40

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

2,382.80

2,146.70

2,276.80

2,125.90

1,993.10

Provisions made

-

-

-

-

-

Depreciation

504.40

488.60

478.70

451.10

428.90

Taxation

798.30

503.00

306.00

212.30

204.10

Net profit / loss

3,441.50

1,529.20

857.90

1,476.20

1,412.90

Extra ordinary item

-8.60

-203.80

-319.30

-187.50

7.30

Prior year adjustments

-

-

-

-

-

Equity capital

100.60

101.20

102.40

102.40

102.40

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

37.52

28.11

24.03

29.77

22.42

GPM (%)

39.93

29.36

24.04

29.57

28.33

NPM (%)

28.91

16.48

10.51

18.76

19.63